When blood sugar is low, GIP can actually increase glucagon secretion, which helps prevent hypoglycemia
Open the full Peptides & GLP-1 resource
With a focus on safety, visible results and accessibility, the team uses only US FDA and approved technology, applies a holistic view to beauty and wellness, and avoids hard-selling or pressure tactics
The most frequent adverse events are gastrointestinal side effects that are mild to moderate, dose-dependent, and transient during the first weeks of treatment
The mechanism of action involves stimulating insulin secretion in a glucose-dependent manner, suppressing glucagon release, slowing gastric emptying, and reducing appetite through central nervous system effects
Reproducible Manufacturing: Produced to meet consistent research standards for reliable results